发明名称 |
PHARMACEUTICAL FORMULATIONS |
摘要 |
There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adjuvant, diluent or carrier, characterized in that the dosage form is adapted to deliver at least 10 % by weight of the darifenacin, or the pharmaceutically acceptable salt thereof, to the lower gastrointestinal tract of the patient. The formulation minimizes unwanted side-effects and increases the bioavailability of darifenacin.</SDO AB>
|
申请公布号 |
CA2230314(C) |
申请公布日期 |
2003.06.24 |
申请号 |
CA19962230314 |
申请日期 |
1996.08.21 |
申请人 |
PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. |
发明人 |
NICHOLS, DONALD JOHN;HUMPHREY, MICHAEL JOHN;DOLAN, THOMAS FRANCIS |
分类号 |
A61K9/22;A61K9/02;A61K9/16;A61K9/20;A61K9/50;A61K31/40;A61K31/4025;A61K47/38;A61K47/48;A61P1/00;A61P1/12;A61P13/02;A61P15/00;A61P31/00;C07D405/06;(IPC1-7):A61K31/40;A61K9/14;A61K9/52 |
主分类号 |
A61K9/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|